Corbus Pharmaceuticals Holdings, Inc.
CRBPCIK 0001595097 · Every Form 4 filed by insiders at this issuer.
Filings
8
Latest Mar 11, 2024
Unique insiders
7
Showing
8 of 8
Page 1
Top insiders
Most active reporters at Corbus Pharmaceuticals Holdings, Inc.
| Name | Roles | Filings |
|---|---|---|
| Chen Bihua | 10% Owner | 3 |
| Cormorant Asset Management, LP | 10% Owner | 3 |
| Cormorant Global Healthcare Master Fund, LP | 10% Owner | 3 |
| Cohen Yuval | OfficerDirector | 2 |
| HOLMER ALAN F | Director | 1 |
| Moran Sean F. | Officer | 1 |
| Smethurst Dominic | Officer | 1 |
All filings
8 Form 4 / 4-A filings, newest first
| Filed | Insider | Top transaction | Shares | Price | Value | |
|---|---|---|---|---|---|---|
| Mar 11, 2024 | Cormorant Asset Management, LP 10% Owner | P | 156,597 | $45.26 | $7,087,580 | |
| Feb 29, 2024 | Smethurst Dominic Chief Medical Officer | A | 50,000 | $0.00 | $0 | |
| Feb 14, 2024 | Cohen Yuval Chief Executive Officer · Director | A | 73,947 | $0.00 | $0 | |
| Feb 14, 2024 | Moran Sean F. Chief Financial Officer | A | 40,176 | $0.00 | $0 | |
| Feb 6, 2024 | Cormorant Asset Management, LP 10% Owner | P | 750,000 | $19.00 | $14,250,000 | |
| Jan 30, 2024 | Cormorant Asset Management, LP 10% Owner | P | 43,754 | $37.49 | $1,640,337 | |
| Jan 30, 2024 | Cohen Yuval Chief Executive Officer · Director | M | 7,179 | $4.97 | $35,680 | |
| Jan 30, 2024 | HOLMER ALAN F Director | M | 629 | $4.97 | $3,126 |
Showing 1–8 of 8
Page 1 of 1
Real-time Form 4 intelligence. Smarter insider tracking.